Login / Signup

Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1.

Ninaad LasradoAnnika RösslerMarjorie RoweAi-Ris Y CollierDan H Barouch
Published in: Vaccine (2024)
A new highly mutated Omicron subvariant BA.2.87.1 has recently been identified with over 30 amino acid mutations in the Spike protein compared with BA.2, BA.5, XBB.1.5, and JN.1 variants. Mutiple mutations in BA.2.87.1 are located in the N-terminal domain (NTD) rather than in the receptor binding domain (RBD) of the Spike protein. We evaluated neutralizing antibody (NAb) responses to BA.2.87.1 because of its highly mutated sequence and its unique NTD region. Our data show that NAb responses to BA.2.87.1 were lower than to BA.2 but higher than to JN.1, suggesting that BA.2.87.1 is not a further antibody escape variant compared with other currently circulating variants. Moreover, XBB.1.5 mRNA boosting increased NAb titers to all variants tested including BA.2.87.1.
Keyphrases
  • amino acid
  • sars cov
  • copy number
  • coronavirus disease
  • zika virus
  • artificial intelligence
  • protein protein
  • transcription factor
  • genome wide